Sanktionen gegen Pharmafirmen wegen Werbung für verschreibungspflichtige Medikamente gegen Adipositas

This question asks about potential sanctions against pharmaceutical companies that advertise prescription-only obesity drugs. It highlights concerns about the marketing practices for these medications. The focus is on whether current regulations are sufficient to prevent misleading or inappropriate advertising, and what actions can be taken against companies that violate these rules.